Frontiers in Bioengineering and Biotechnology (Mar 2020)

Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia

  • Fengxuan Han,
  • Fengxuan Han,
  • Jiayuan Wang,
  • Jiayuan Wang,
  • Luguang Ding,
  • Luguang Ding,
  • Yuanbin Hu,
  • Wenquan Li,
  • Zhangqin Yuan,
  • Zhangqin Yuan,
  • Qianping Guo,
  • Qianping Guo,
  • Caihong Zhu,
  • Caihong Zhu,
  • Li Yu,
  • Li Yu,
  • Huan Wang,
  • Huan Wang,
  • Zhongliang Zhao,
  • Zhongliang Zhao,
  • Luanluan Jia,
  • Luanluan Jia,
  • Jiaying Li,
  • Jiaying Li,
  • Yingkang Yu,
  • Yingkang Yu,
  • Weidong Zhang,
  • Weidong Zhang,
  • Genglei Chu,
  • Song Chen,
  • Song Chen,
  • Bin Li,
  • Bin Li,
  • Bin Li

DOI
https://doi.org/10.3389/fbioe.2020.00083
Journal volume & issue
Vol. 8

Abstract

Read online

Exploring innovative solutions to improve the healthcare of the aging and diseased population continues to be a global challenge. Among a number of strategies toward this goal, tissue engineering and regenerative medicine (TERM) has gradually evolved into a promising approach to meet future needs of patients. TERM has recently received increasing attention in Asia, as evidenced by the markedly increased number of researchers, publications, clinical trials, and translational products. This review aims to give a brief overview of TERM development in Asia over the last decade by highlighting some of the important advances in this field and featuring major achievements of representative research groups. The development of novel biomaterials and enabling technologies, identification of new cell sources, and applications of TERM in various tissues are briefly introduced. Finally, the achievement of TERM in Asia, including important publications, representative discoveries, clinical trials, and examples of commercial products will be introduced. Discussion on current limitations and future directions in this hot topic will also be provided.

Keywords